Chalmersforskare: Bättre riskbedömning med lipoprotein än kolesterol

I stället för att mäta kolesterolvärdet i blodet för att förutse risken för hjärtinfarkt kan ett enkelt test av lipoproteinmarkörer ge bättre information. Det h...

Danish obesity success causes recruitment problems in southern Sweden

The substantial expansion of Danish Novo Nordisk is affecting companies in southern Sweden, which are finding it increasingly difficult to compete for attractive staff.

He saved lives with his theories – was ostracised and ended up in a mental hospital

Hungarian doctor Ignaz Semmelweis (1818-1865) undoubtedly possessed plenty of persistence, diligence and sound reasoning skills – but he was hardly blessed with...

Biosimilars bring price pressure, but are they sufficiently used?

When biosimilars were introduced just over 16 years ago, hopes were raised that they would give many more patients access to effective but otherwise extremely e...

Danska life science-industrin står för rekordhög export

Den danska exporten av life science-produkter har ökat explosionsartat, med en tillväxt på 227 procent sedan 2008 och utgjorde 2023 så mycket som 19 procent av ...

Improve Productivity and Accessibility with Award-winning Human-Centered Design

Enhance your workflow with integrated intelligence.

ZEISS presents the "Quality Innovation Summit"

A global event on the future of quality assurance.

Introducing ZEISS arivis Pro 4.2

ZEISS arivis software enhances custom microscopy image analysis.

Bioarctics forskningschef Johanna Fälting tar plats i VR:s ämnesråd

Bioarctics forskningschef Johanna Fälting och läkaren Markus Lingman har utsetts till nya ledamöter i Vetenskapsrådets ämnesråd för medicin och hälsa.

Fysikpriset till forskare inom maskininlärning

Årets Nobelpris i fysik går till John J Hopfield och Geoffrey E Hinton för deras insatser inom maskininlärning.

Swedish pavilion with healthcare companies at Ukraine fair – “Ukraine is being rebuilt right now”

Private companies and public authorities are both needed in the reconstruction of Ukraine, said Minister for Health Care, Acko Ankarberg Johansson, in her openi...

Tirzepatide approved for obesity by the FDA – to be branded as Zepbound

Diabetes drug tirzepatide has now also been approved in the US for treating obesity.

NorthX Biologics Matfors AB

Bayer has cut 1,500 roles – so far

German chemical and pharmaceutical group Bayer cut more than 1,500 roles in the first quarter alone– and most of them were management positions.

Recipharm säljer av fem svenska anläggningar

Svenska kontraktstillverkaren Recipharm säljer sina anläggningar i Solna, Strängnäs, Höganäs, Karlskoga samt Uppsala OTC Development till det amerikanska privat...

Samuel Lagercrantz: “Companies that do this successfully will take the lead”

The development of new medicines and medical technologies should not focus too narrowly on prolonging life. It is equally important to develop treatments that r...

Genterapi mot blödarsjuka visade effekt ännu efter fyra år

Den omtalade genterapin Hemgenix mot hemofili B visar god effekt fortfarande fyra år efter att behandlingen utförts.

RegFile AB

Extensive agreements signed at Scilifelab

Four agreements were signed between Swedish and Dutch life science players in connection with the Dutch state visit earlier this month.

SMC Corporation Appoints Bianca Brunell as New General Manager for the Nordic and Baltic Countries

SMC Corporation is pleased to announce the appointment of Bianca Brunell as the new General Manager for SMC’s Nordic and Baltic countries, effective June 1, 2024.

Samuel Lagercrantz: ”Forskare, se upp för rovtidskrifter!”

”Precis som vi alla behöver vara vaksamma i vår vardag på vad som är sant och vad som är falskt, behöver forskare vara vaksamma på vilka tidskrifter de publicer...

19 medicines in Sweden are under investigation in a major EMA inquiry

unless new evidence can be provided that they are up to standard.

Setback for pharmaceutical companies in the Zantac case

A Delaware judge has ruled in favour of allowing expert witnesses to testify in a case involving the now-cancelled drug Zantac and its potential carcinogenicity.

Eli Lilly to build a USD 2.5-billion plant in Germany

US-based Eli Lilly is planning a huge investment of USD 2.5 billion, equivalent to around SEK 26.5 billion, in a new production facility in Alzey, Germany.